Announced: Health Technology Assessment Policy and Methods Review Recommendations Implementation Group

News

Rare Voices Australia’s Chief Executive Officer, Nicole Millis, is pleased to accept a consumer role on the newly announced Implementation Advisory Group (IAG) for the Health Technology Assessment (HTA) Review Report following an expression of interest process. The Hon Mark Butler MP, Minister for Health and Aged Care, announced the IAG while delivering a speech at Parliament House. Read the Minister’s full speech on the Department of Health and Aged Care’s website.

The IAG will be chaired by renowned cardiologist and former Chair of the Pharmaceutical Benefits Advisory Committee, Professor Andrew Wilson. Two members have been appointed to represent consumer interests – one with expertise in rare diseases and the other with expertise in more common diseases.

RVA congratulates Professor Wilson and the other IAG members on their appointment:

  • Dr Lorraine Anderson – Medical Director, Kimberley Aboriginal Medical Services (clinical representative)
  • Dr Richard Mitchell – Head of Clinical Services, Kids Cancer Centre (clinical representative)
  • Kirsten Pilatti – Chief Executive Officer, Breast Cancer Network Australia (consumer representative)
  • Elizabeth de Somer – Chief Executive Officer, Medicines Australia (industry representative)
  • Anne Harris – Deputy Chair, Medicines Australia Board (industry representative)